1. Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease. Issue 8 (10th March 2023) Authors: Cobleigh, Melody A.; Vogel, Charles L.; Tripathy, Debu; Robert, Nicholas J.; Scholl, Susy; Fehrenbacher, Louis; Wolter, Janet M.; Paton, Virginia; Shak, Steven; Lieberman, Gracie; Slamon, Dennis J. Journal: Journal of clinical oncology Issue: Volume 41:Issue 8(2023) Page Start: 1501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial. Issue 9 (September 2019) Authors: Friedlander, Michael; Meniawy, Tarek; Markman, Ben; Mileshkin, Linda; Harnett, Paul; Millward, Michael; Lundy, Joanne; Freimund, Alison; Norris, Christie; Mu, Song; Wu, John; Paton, Virginia; Gao, Bo Journal: Lancet oncology Issue: Volume 20:Issue 9(2019) Page Start: 1306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors. Issue 1 (14th June 2020) Authors: Desai, Jayesh; Deva, Sanjeev; Lee, Jong Seok; Lin, Chia-Chi; Yen, Chia-Jui; Chao, Yee; Keam, Bhumsuk; Jameson, Michael; Hou, Ming-Mo; Kang, Yoon-Koo; Markman, Ben; Lu, Chang-Hsien; Rau, Kun-Ming; Lee, Kyung-Hun; Horvath, Lisa; Friedlander, Michael; Hill, Andrew; Sandhu, Shahneen; Barlow, Paula; W... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗